1. Market Research
  2. > Healthcare
  3. > Medical Supply Market Trends
  4. > Collagens - Pipeline Review, 2015

Collagens - Pipeline Review, 2015

  • September 2015
  • -
  • Global Data
  • -
  • 95 pages

Collagens - Pipeline Review, 2015

Summary

GlobalData's Medical Devices sector report, “Collagens - Pipeline Review, 2015" provides an overview of Collagens currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Collagens pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Collagens under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Collagens and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Collagens under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Collagens - Pipeline Review, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Collagens Overview 7
3 Products under Development 8
3.1 Collagens - Pipeline Products by Stage of Development 8
3.2 Collagens - Pipeline Products by Segment 9
3.3 Collagens - Pipeline Products by Territory 10
3.4 Collagens - Pipeline Products by Regulatory Path 11
3.5 Collagens - Pipeline Products by Estimated Approval Date 12
3.6 Collagens - Ongoing Clinical Trials 13
4 Collagens - Pipeline Products under Development by Companies 14
4.1 Collagens Companies - Pipeline Products by Stage of Development 14
4.2 Collagens - Pipeline Products by Stage of Development 15
5 Collagens Companies and Product Overview 17
5.1 Advanced Medical Solutions Group plc Company Overview 17
5.1.1 Advanced Medical Solutions Group plc Pipeline Products and Ongoing Clinical Trials Overview 17
5.2 AGAM Biological Products Company Overview 19
5.2.1 AGAM Biological Products Pipeline Products and Ongoing Clinical Trials Overview 19
5.3 Alliqua BioMedical, Inc. Company Overview 21
5.3.1 Alliqua BioMedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 21
5.4 botiss dental GmbH Company Overview 23
5.4.1 botiss dental GmbH Pipeline Products and Ongoing Clinical Trials Overview 23
5.5 CollPlant Ltd. Company Overview 28
5.5.1 CollPlant Ltd. Pipeline Products and Ongoing Clinical Trials Overview 28
5.6 Conversion Energy Enterprises Company Overview 34
5.6.1 Conversion Energy Enterprises Pipeline Products and Ongoing Clinical Trials Overview 34
5.7 Covalon Technologies Ltd. Company Overview 36
5.7.1 Covalon Technologies Ltd. Pipeline Products and Ongoing Clinical Trials Overview 36
5.8 EternoGen, LLC Company Overview 39
5.8.1 EternoGen, LLC Pipeline Products and Ongoing Clinical Trials Overview 39
5.9 Holista CollTech Limited Company Overview 40
5.9.1 Holista CollTech Limited Pipeline Products and Ongoing Clinical Trials Overview 40
5.10 Innocoll Technologies Limited Company Overview 41
5.10.1 Innocoll Technologies Limited Pipeline Products and Ongoing Clinical Trials Overview 41
5.11 Jellagen Pty Ltd Company Overview 49
5.11.1 Jellagen Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 49
5.12 Kyeron BV Company Overview 51
5.12.1 Kyeron BV Pipeline Products and Ongoing Clinical Trials Overview 51
5.13 Medtronic plc Company Overview 52
5.13.1 Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 52
5.14 Nanotherapeutics, Inc. Company Overview 56
5.14.1 Nanotherapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 56
5.15 PlasMedica Technologies Limited Company Overview 57
5.15.1 PlasMedica Technologies Limited Pipeline Products and Ongoing Clinical Trials Overview 57
5.16 Shire Plc Company Overview 66
5.16.1 Shire Plc Pipeline Products and Ongoing Clinical Trials Overview 66
5.17 Taxus Cardium Pharmaceuticals Group Inc. Company Overview 68
5.17.1 Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products and Ongoing Clinical Trials Overview 68
5.18 ULURU Inc. Company Overview 70
5.18.1 ULURU Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
6 Collagens- Recent Developments 72
7 Appendix 92
7.1 Methodology 92
7.2 About GlobalData 94
7.3 Contact Us 95
7.4 Disclaimer 95

1.1 List of Tables
Table 1: Collagens - Pipeline Products by Stage of Development 8
Table 2: Collagens - Pipeline Products by Segment 9
Table 3: Collagens - Pipeline Products by Territory 10
Table 4: Collagens - Pipeline Products by Regulatory Path 11
Table 5: Collagens - Pipeline Products by Estimated Approval Date 12
Table 6: Collagens - Ongoing Clinical Trials 13
Table 7: Collagens Companies - Pipeline Products by Stage of Development 14
Table 8: Collagens - Pipeline Products by Stage of Development 15
Table 9: Advanced Medical Solutions Group plc Pipeline Products and Ongoing Clinical Trials Overview 17
Table 10: Reinforced Collagen - Product Status 18
Table 11: Reinforced Collagen - Product Description 18
Table 12: AGAM Biological Products Pipeline Products and Ongoing Clinical Trials Overview 19
Table 13: Wound Dressing Pad - Product Status 20
Table 14: Wound Dressing Pad - Product Description 20
Table 15: Alliqua BioMedical, Inc. Pipeline Products and Ongoing Clinical Trials Overview 21
Table 16: Tissue Repair Scaffold - Product Status 22
Table 17: Tissue Repair Scaffold - Product Description 22
Table 18: botiss dental GmbH Pipeline Products and Ongoing Clinical Trials Overview 23
Table 19: collacone - Product Status 24
Table 20: collacone - Product Description 24
Table 21: collprotect Membrane - Product Status 25
Table 22: collprotect Membrane - Product Description 25
Table 23: Jason Collagen Fleece - Product Status 26
Table 24: Jason Collagen Fleece - Product Description 26
Table 25: Jason Membrane - Product Status 27
Table 26: Jason Membrane - Product Description 27
Table 27: CollPlant Ltd. Pipeline Products and Ongoing Clinical Trials Overview 28
Table 28: VergenixFG - Product Status 29
Table 29: VergenixFG - Product Description 29
Table 30: VergenixWD - Product Status 30
Table 31: VergenixWD - Product Description 30
Table 32: CollPlant Ltd. - Ongoing Clinical Trials Overview 31
Table 33: VergenixWD - A Clinical Study For The Treatment Of Chronic Wounds In Diabetes Patients 32
Table 34: VergenixFG - Assessment of Vergenix Flowable Gel Product Safety and Efficacy in Treatment of Wounds 33
Table 35: Conversion Energy Enterprises Pipeline Products and Ongoing Clinical Trials Overview 34
Table 36: Photoactivated Collagen Dressing - Product Status 35
Table 37: Photoactivated Collagen Dressing - Product Description 35
Table 38: Covalon Technologies Ltd. Pipeline Products and Ongoing Clinical Trials Overview 36
Table 39: Hemostatic Delivering FNS - Product Status 37
Table 40: Hemostatic Delivering FNS - Product Description 37
Table 41: Hemostatic Dressing Delivering PLT - Product Status 38
Table 42: Hemostatic Dressing Delivering PLT - Product Description 38
Table 43: EternoGen, LLC Pipeline Products and Ongoing Clinical Trials Overview 39
Table 44: Collagen Scaffold - Wound Healing - Product Status 39
Table 45: Collagen Scaffold - Wound Healing - Product Description 39
Table 46: Holista CollTech Limited Pipeline Products and Ongoing Clinical Trials Overview 40
Table 47: Ovicoll M - Product Status 40
Table 48: Ovicoll M - Product Description 40
Table 49: Innocoll Technologies Limited Pipeline Products and Ongoing Clinical Trials Overview 41
Table 50: Cogenzia - Product Status 42
Table 51: Cogenzia - Product Description 42
Table 52: CollaRx Gentamicin Surgical Implant - Product Status 43
Table 53: CollaRx Gentamicin Surgical Implant - Product Description 43
Table 54: COLLIEVA Ag - Product Status 44
Table 55: COLLIEVA Ag - Product Description 44
Table 56: DermaSIL (CM003) - Product Status 45
Table 57: DermaSIL (CM003) - Product Description 45
Table 58: Durieva - Product Status 46
Table 59: Durieva - Product Description 46
Table 60: Second Generation Collagen Matrix - Product Status 47
Table 61: Second Generation Collagen Matrix - Product Description 47
Table 62: Third Generation Collagen Matrix - Product Status 48
Table 63: Third Generation Collagen Matrix - Product Description 48
Table 64: Jellagen Pty Ltd Pipeline Products and Ongoing Clinical Trials Overview 49
Table 65: Collagen-based Wound Healing Device - Product Status 50
Table 66: Collagen-based Wound Healing Device - Product Description 50
Table 67: Kyeron BV Pipeline Products and Ongoing Clinical Trials Overview 51
Table 68: Wound Management Device - Product Status 51
Table 69: Wound Management Device - Product Description 51
Table 70: Medtronic plc Pipeline Products and Ongoing Clinical Trials Overview 52
Table 71: Duratech - Abdominal Wall Reconstruction - Product Status 53
Table 72: Duratech - Abdominal Wall Reconstruction - Product Description 53
Table 73: Duratech - Hernia Repair - Product Status 54
Table 74: Duratech - Hernia Repair - Product Description 54
Table 75: Duratech - Wound Care - Product Status 55
Table 76: Duratech - Wound Care - Product Description 55
Table 77: Nanotherapeutics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 56
Table 78: ntSPONGE - Product Status 56
Table 79: ntSPONGE - Product Description 56
Table 80: PlasMedica Technologies Limited Pipeline Products and Ongoing Clinical Trials Overview 57
Table 81: PlasmaPly - Burns and Wounds - Product Status 58
Table 82: PlasmaPly - Burns and Wounds - Product Description 58
Table 83: PlasmaPly - Diabetic Foot Ulcers - Product Status 59
Table 84: PlasmaPly - Diabetic Foot Ulcers - Product Description 59
Table 85: PlasmaPly - Internal Ulcers - Product Status 60
Table 86: PlasmaPly - Internal Ulcers - Product Description 60
Table 87: PlasmaPly - Military Acute Injuries - Product Status 61
Table 88: PlasmaPly - Military Acute Injuries - Product Description 61
Table 89: PlasmaPly - Pressure Ulcers - Product Status 62
Table 90: PlasmaPly - Pressure Ulcers - Product Description 62
Table 91: PlasmaPly - Skin Disorders - Product Status 63
Table 92: PlasmaPly - Skin Disorders - Product Description 63
Table 93: PlasmaPly - Venous Ulcers - Product Status 64
Table 94: PlasmaPly - Venous Ulcers - Product Description 64
Table 95: PlasmaPly Drug Delivery Matrix - Product Status 65
Table 96: PlasmaPly Drug Delivery Matrix - Product Description 65
Table 97: Shire Plc Pipeline Products and Ongoing Clinical Trials Overview 66
Table 98: Recombinant Collagen VII (rC7) - Product Status 67
Table 99: Recombinant Collagen VII (rC7) - Product Description 67
Table 100: Taxus Cardium Pharmaceuticals Group Inc. Pipeline Products and Ongoing Clinical Trials Overview 68
Table 101: Excellagen - Expanded Structural And Functional Properties - Product Status 69
Table 102: Excellagen - Expanded Structural And Functional Properties - Product Description 69
Table 103: ULURU Inc. Pipeline Products and Ongoing Clinical Trials Overview 70
Table 104: Altrazeal Collagen - Product Status 71
Table 105: Altrazeal Collagen - Product Description 71
Table 106: Glossary 93

1.2 List of Figures
Figure 1: Collagens - Pipeline Products by Stage of Development 8
Figure 2: Collagens - Pipeline Products by Segment 9
Figure 3: Collagens - Pipeline Products by Territory 10
Figure 4: Collagens - Pipeline Products by Regulatory Path 11
Figure 5: Collagens - Pipeline Products by Estimated Approval Date 12
Figure 6: Collagens - Ongoing Clinical Trials 13

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Advanced Wound Care Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Advanced Wound Care Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • October 2016
  • by Transparency Market Research

Advanced Wound Care Management Market: Overview The market for wound care is growing phenomenally, due to growing advancement is treating complex wounds. Advanced wound care market is anticipated to grow ...

Animal Wound Care Market by Product Animal & End User - Global Forecast to 2021

Animal Wound Care Market by Product Animal & End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global animal wound care market is estimated to grow at a CAGR of 6.7% from 2016 to 2021, to reach USD 1,134.0 million by 2021 from USD 818.8 million in 2016. The growth of this market is mainly attributed ...

Burn Care Market by Product, Biologics, Traditional), Depth, End-Users, Physician Clinics, Homecare - Forecast to 2021

Burn Care Market by Product, Biologics, Traditional), Depth, End-Users, Physician Clinics, Homecare - Forecast to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The burn care market is expected to reach USD 2.33 billion by 2021 from USD 1.68 billion in 2016, at a CAGR of 6.8% from 2016 to 2021. Market growth can be attributed to factors such as rising incidence ...

Global Advanced Wound Care Industry

September 2016 $ 4950

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.